Fulgent Genetics's top three insider shareholders as of June 06, 2026 are Hanlin Gao (Chief Scientific Officer, 994.65K shares), Ming Hsieh (Chief Executive Officer, 900.63K shares), Jian Xie (President And Coo, 375.31K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John C Bolger | - | 5,100 | 0 | 03 Aug, 2022 |
| Paul Kim | Cfo And Treasurer | 368,547 | 0 | 02 Mar, 2026 |
| Ming Hsieh | Chief Executive Officer | 900,634 | 0 | 02 Mar, 2026 |
| Regina E Groves | - | 16,982 | 0 | 19 May, 2025 |
| Hanlin Gao | Chief Scientific Officer | 994,652 | 0 | 02 Mar, 2026 |
| Yun Yen | - | 2,000 | 0 | 20 May, 2022 |
| Linda Marsh | - | 27,641 | 0 | 19 May, 2025 |
| Jian Xie | President And Coo | 375,313 | 0 | 02 Mar, 2026 |
| Michael Nohaile | - | 19,020 | 0 | 19 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Ming Hsieh | Forward sale contract (obligation to sell) | D | 750,000 | - | 0 | I | J |
| 09 Mar, 2026 | Ming Hsieh | Forward sale contract (obligation to sell) | D | 750,000 | - | 0 | I | J |
| 09 Mar, 2026 | Ming Hsieh | Forward sale contract (obligation to sell) | D | 750,000 | - | 0 | I | J |
| 09 Mar, 2026 | Ming Hsieh | Forward sale contract (obligation to sell) | D | 750,000 | - | 0 | I | J |
| 26 Feb, 2026 | Hanlin Gao | Common Stock | D | 897 | $24.76 | 1,002,080 | D | F |
| 26 Feb, 2026 | Hanlin Gao | Common Stock | D | 897 | $24.76 | 1,002,080 | D | F |
| 26 Feb, 2026 | Paul Kim | Common Stock | D | 1,168 | $24.76 | 378,027 | D | F |
| 26 Feb, 2026 | Jian Xie | Common Stock | D | 1,140 | $24.76 | 384,539 | D | F |
| 26 Feb, 2026 | Ming Hsieh | Common Stock | D | 2,949 | $24.76 | 918,200 | D | F |
| 26 Feb, 2026 | Paul Kim | Common Stock | D | 1,168 | $24.76 | 378,027 | D | F |
| 26 Feb, 2026 | Jian Xie | Common Stock | D | 1,140 | $24.76 | 384,539 | D | F |
| 26 Feb, 2026 | Ming Hsieh | Common Stock | D | 2,949 | $24.76 | 918,200 | D | F |
| 01 Mar, 2026 | Paul Kim | Common Stock | D | 1,133 | $15.33 | 376,894 | D | F |
| 01 Mar, 2026 | Hanlin Gao | Common Stock | D | 1,018 | $15.33 | 1,001,062 | D | F |
| 01 Mar, 2026 | Jian Xie | Common Stock | D | 1,079 | $15.33 | 383,460 | D | F |
| 01 Mar, 2026 | Paul Kim | Common Stock | D | 1,133 | $15.33 | 376,894 | D | F |
| 01 Mar, 2026 | Ming Hsieh | Common Stock | D | 17,566 | $15.33 | 900,634 | D | F |
| 01 Mar, 2026 | Jian Xie | Common Stock | D | 1,079 | $15.33 | 383,460 | D | F |
| 01 Mar, 2026 | Hanlin Gao | Common Stock | D | 1,018 | $15.33 | 1,001,062 | D | F |
| 01 Mar, 2026 | Ming Hsieh | Common Stock | D | 17,566 | $15.33 | 900,634 | D | F |